(MENAFN- EIN Presswire)
digital therapeutics market
The growing Acquisition of the digital world and profound approach to the internet worldwide a prominent factor driving the digital therapeutics market
The growing acquisition of the digital world and profound approach to the internet worldwide a prominent factor driving the digital therapeutics market.” - Polaris
market ResearchNEW YORK CITY, NY, UNITED STATES, January 16, 2025 /EINPresswire / -- The digital therapeutics market forecast for 2032 is a specialized study of the
industry with a specific concentration on the global market trend analysis.
The digital therapeutics market is augmenting. The market is approximated to reach USD 70.63 billion by 2032. It was valued at USD 6.89 billion in 2023. It exhibited a CAGR of 29.5% from 2024 to 2032.
What are Digital Therapeutics?
Digital therapeutics are a constituent of digital health that convey therapeutic intermediation instantly to patients through proof-dependent, clinically assessed software for illness handling. It cohesively indicates all platforms and technologies that offer digital solutions to enhance healthcare conveyance.
Download Free Sample PDF Copy of the Report:
/request-for-sample?utm_source=Ein&utm_medium=Ein&utm_campaign=Ein&utm_id=01
The commodities of digital therapeutics circumscribe progressive technologies to sanction superlative practice in outline, clinical reinforcement, and data security. The development in the aggregate of internet users is because of several elements, such as the development of smartphone technologies and progression in computing software and hardware, impacting the digital therapeutics market growth favourably.
Who Makes Digital Therapeutics?
.Proteus Digital Health, Inc.
.Fitbit, Inc.
.Pear Therapeutics, Inc.
.Kaia Health
.Happify, Inc.
.Medtronic Plc.
.Omada Health, Inc.
.Livongo Health, Inc.
.Voluntis, Inc.
.Canary Health
.Mindable Health GmbH.
are some of the leading players in the digital therapeutics market.
The market is continuously altering, with several firms functioning to invent and be noticeable.
Some of the latest developments in the market are:
.In May 2024, Otsuka Pharmaceutical instigated a contemporary to commercialize its digital therapeutic, Rejoyn, and augment it into digital therapeutics and linked health commodities.
.In June 2024, the Digital Therapeutics Alliance (DTA) divulged its strategies to instigate an accreditation program for digital therapeutics through a contemporary association with DirectTrust.
What's Driving Market Forward?
Rise in Digital Technology: The surge in the usage of digital technology propels the market. A substantial share of the population now has permission to access smartphones and other hardware, which has speeded the acquisition of digital tools covering several sectors, including healthcare. For instance, as per the World Bank, there were 8.5 billion mobile benefactions globally in 2022, rising from 338 million in 1981.
Advancement in Service-Oriented Software: Progression in service-oriented software is expected to push the market. Service-oriented architecture (SOA) permits for advancement of flexible, scalable, and centralizing digital health solutions that can adjust to the requirements of several users and healthcare systems. This, in turn, is having a favorable impact on digital therapeutics market sales.
Growing Disbursement on Digital Media: The market is encountering notable growth due to the growing aggregate of people disbursement on digital media every day. The surge in the usage of contemporary software is causing substantial approval of healthcare instruments and software among the general population.
Request for a Discount on this Report Before Purchase:
/request-for-discount-pricing?utm_source=Ein&utm_medium=Ein&utm_campaign=Ein&utm_id=01
Which Region Leads Market Growth?
North America: North America accounted for the largest digital therapeutics market share. The region's robust growth is primarily due to it having the prominent allocation of the population with internet access and progressive software technologies.
Asia Pacific: Asia Pacific is anticipated to witness significant growth from 2024 to 2032. This can be attributed to the government's capabilities to digitalize healthcare sectors.
How Is Market Segmentation Done?
By Revenue Model Outlook
.Subscription
.Value-Based
.One Time Purchase
By Application Outlook
.Diabetes
.Obesity
.CVD
.CNS Disease
.Respiratory Diseases
.Smoking Cessation
.Lifestyle Management
.Preventive Applications
.Others
By End Users Outlook
.Patients
.Providers
.Payers
.Employers
.Others
By Regional Outlook
.North America
oUS
oCanada
.Europe
oGermany
oFrance
oUK
oItaly
oSpain
oNetherlands
oRussia
oRest of Europe
.Asia Pacific
oChina
oJapan
oIndia
oMalaysia
oSouth Korea
oIndonesia
oAustralia
oRest of Asia Pacific
.Middle East & Africa
oSaudi Arabia
oUAE
oIsrael
oSouth Africa
oRest of the Middle East & Africa
.Latin America
oMexico
oBrazil
oArgentina
oRest of Latin America
Inquire more about this Report Before Purchase:
/inquire-before-buying?utm_source=Ein&utm_medium=Ein&utm_campaign=Ein&utm_id=01
FAQs:
How much is the digital therapeutics market?
The market size was valued at USD 6.89 billion in 2023 and is projected to grow to USD 70.63 billion by 2032.
What are the segments covered in the digital therapeutics market?
The segments covered are by revenue model, application and end users.
Which region led the market share?
North America led the market share.
What is the growth rate of the market?
The market is projected to grow at a CAGR of 29.5% from 2024 to 2032.
Browse More Research Reports:
Viral Sensitizers Market:
Blastic Plasmacytoid Dendritic Cell Neoplasm Marke:
Artificial Tendons and Ligaments Market:
Targeted DNA RNA Sequencing Market:
In Vitro Diagnostics Market:
About Polaris Market Research & Consulting, Inc:
Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for PMR's clientele spread across different enterprises. We at Polaris are obliged to serve PMR's diverse customer base present across the industries of healthcare, technology, semiconductors, and chemicals among various other industries present around the world. We strive to provide PMR's customers with updated information on innovative technologies, high-growth markets, emerging business environments, and the latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities. Adept with a highly competent, experienced, and extremely qualified team of experts comprising SMEs, analysts, and consultants, we at Polaris endeavor to deliver value-added business solutions to PMR's customers.
Likhil G
Polaris Market Research and Consulting
+1 929-297-9727
...
Visit us on social media:
Facebook
X
LinkedIn
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability
for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this
article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
MENAFN16012025003118003196ID1109097806